Our portfolio

This is our portfolio with which we are 100% transparent.

Since 2015 we have built up a diversified portfolio with growing value. We put a lot of work and specialized knowledge into selecting the best investment opportunities - that's why we only make public approximately 3% of those we analyse.

€146 million

in co-investment

€76 million

direct investment

129

investee companies

94%

in business

All the investment opportunities we publish in Capital Cell have a reference investor who has conducted its own analysis, its own due diligence and validated the price per share. This reinforces our confidence that the project and its team are capable of generating a return.


Some benchmark investors of companies we have published:

719.000€
Round size
  • April   2026
  • Biotechnology
  • In business
See campaign
680.000€
Round size
  • March   2026
  • Biotechnology
  • In business
See campaign
702.000€
Round size
  • February   2026
  • Biotechnology
  • In business
See campaign
619.000€
Round size
  • February   2026
  • Medical devices
  • In business
See campaign
1.019.000€
Round size
  • February   2026
  • Medical devices
  • In business
See campaign
2.750.000€
Round size
  • January   2026
  • New drugs
  • In business
See campaign
914.000€
Round size
  • December   2025
  • Diagnostics
  • In business
See campaign
585.000€
Round size
  • December   2025
  • Biotechnology
  • In business
See campaign
619.000€
Round size
  • November   2025
  • Medical devices
  • In business
See campaign
2.199.000€
Round size
  • November   2025
  • New drugs
  • In business
See campaign
759.000€
Round size
  • November   2025
  • Medical devices
  • In business
See campaign
4.200.000€
Round size
  • October   2025
  • Biotechnology
  • In business
See campaign
604.000€
Round size
  • September   2025
  • New drugs
  • In business
See campaign
1.183.000€
Round size
  • September   2025
  • Biotechnology
  • In business
See campaign
231.000€
Round size
  • August   2025
  • Medical devices
  • In business
See campaign
3.128.000€
Round size
  • July   2025
  • Digital health
  • In business
See campaign
890.000€
Round size
  • July   2025
  • New drugs
  • In business
See campaign
354.000€
Round size
  • June   2025
  • Biotechnology
  • In business
See campaign
1.556.000€
Round size
  • June   2025
  • New drugs
  • In business
See campaign
1.011.000€
Round size
  • May   2025
  • Medical devices
  • In business
See campaign
722.000€
Round size
  • May   2025
  • Biotechnology
  • In business
See campaign